Suspended

CANABICDoes a BI Conducted by General Practitioners Reduce Consumption of Canabis in 15 to 25 Years Old ?

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Brief Intervention

Behavioral
Who is being recruted

Behavior+1

+ Compulsive Behavior

+ Impulsive Behavior

From 15 to 25 Years
See all eligibility criteria
How is the trial designed

Interventional
Study Start: March 2012
See protocol details

Summary

Principal SponsorUniversity Hospital, Clermont-Ferrand
Study ContactPatrick LACARIN
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2012

Actual date on which the first participant was enrolled.

General organisation of the study * Recruitment of the GP: 3 months (from December 2011 to March 2012) * Training of the intervention group GP during a one-day training, in March 2012, on 3 thematic: relationship between GP and adolescent, cannabis and BI; by an expert team * Inclusion period : 10 months (from April 2012 to January 2013). The included patients will be followed for 12 months. There are 3 follow up consultations at 3, 6 and 12 months. * First consultation used to the inclusion: Information to the patient and collection of the patient non opposition (without informing the intervention objectives in the control group). Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health. Inclusion criteriae : repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day. In the IG : achievment of the BI with the adolescent. In each group, making appointment with the patient at 3 months • Follow up consultations : At 3, 6 and 12 months. Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.

Official TitleDoes a BI Conducted by General Practitioners Reduce Consumption of Canabis in 15 to 25 Years Old ?
NCT01433692
Principal SponsorUniversity Hospital, Clermont-Ferrand
Study ContactPatrick LACARIN
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

750 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 15 to 25 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorCompulsive BehaviorImpulsive BehaviorBehavior, Addictive

Criteria

Inclusion Criteria: * Adolescents 15 to 25 years Repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day. The patient must have given his informed consent and signed the form of no objection Exclusion Criteria: * Adolescents with psychiatric illness considered by the attending physician in acute decompensated * Intellectual Disability * Hard of hearing * No French language skills * Patient already under treatment for the withdrawal of an addicition to cannabis or other substance * Adolescents who participated in the preliminary qualitative study

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Group II

Experimental

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

CHU Clermont-Ferrand

Clermont-Ferrand, FranceOpen CHU Clermont-Ferrand in Google Maps
SuspendedOne Study Center